Recently targeted kinases and their inhibitors-the path to clinical trials.

Recently targeted kinases and their inhibitors-the path to clinical trials.

他のバージョン（1件）を表示する

Protein kinases have emerged as one of the most important drug target families for the treatment of cancer. To date, 28 inhibitors with reported activity versus one or multiple kinases have been approved for clinical use. However, the majority of new clinical trials are focused on new subindications...

書誌詳細
主要な著者:	Knapp, S, Sundström, M
フォーマット:	Journal article
言語:	English
出版事項:	Elsevier 2014

類似資料

Recently targeted kinases and their inhibitors - the path to clinical trials
著者:: Knapp, S, 等
出版事項: (2014)

Insights for the development of specific kinase inhibitors by targeted structural genomics.
著者:: Fedorov, O, 等
出版事項: (2007)

A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
著者:: Fedorov, O, 等
出版事項: (2007)

Targeting kinases for the treatment of inflammatory diseases.
著者:: Müller, S, 等
出版事項: (2010)

Kinase inhibitor selectivity profiling using differential scanning fluorimetry.
著者:: Fedorov, O, 等
出版事項: (2012)

Clinical Potential of Kinase Inhibitors in Combination with Immune Checkpoint Inhibitors for the Treatment of Solid Tumors
著者:: Ahn, Ryuhjin, 等
出版事項: (2021)

Development of bioreductive inhibitors of checkpoint kinase 1 to target hypoxic tumours
著者:: Körner, C
出版事項: (2015)

High-throughput structural characterisation of therapeutic protein targets.
著者:: Marsden, B, 等
出版事項: (2006)

High-throughput structural characterisation of therapeutic protein targets
著者:: Marsden, B, 等
出版事項: (2006)

Synthesis, kinase inhibitory potencies, and in vitro antiproliferative evaluation of new Pim kinase inhibitors.
著者:: Akué-Gédu, R, 等
出版事項: (2009)

Discovery of BET bromodomain inhibitors and their role in target validation
著者:: Mueller, S, 等
出版事項: (2014)

The cysteinome of protein kinases as a target in drug development
著者:: Chaikuad, A, 等
出版事項: (2018)

A first clinical trial of a novel narrow spectrum kinase inhibitor TOP1288 in patients with ulcerative colitis
著者:: Taylor, M, 等
出版事項: (2017)

Network modeling of kinase inhibitor polypharmacology reveals pathways targeted in chemical screens
著者:: Beeharry, Neil, 等
出版事項: (2018)

Versatile selective kinase inhibitors: Chemistry and biology of indirubins
著者:: Gaboriaud-Kolar, N, 等
出版事項: (2012)

Dual kinase-bromodomain inhibitors for rationally designed polypharmacology.
著者:: Ciceri, P, 等
出版事項: (2014)

Novel approaches for targeting kinases: allosteric inhibition, allosteric activation and pseudokinases.
著者:: Cowan-Jacob, S, 等
出版事項: (2014)

Functional characterization of the cyclin-dependent kinase inhibitor p21 by gene targeting in the mouse
著者:: Brugarolas, James (James Burfau), 1969-
出版事項: (2009)

Crystal structure of the PIM2 kinase in complex with an organoruthenium inhibitor.
著者:: Bullock, A, 等
出版事項: (2009)

DFG-1 residue controls inhibitor binding mode and affinity, providing a basis for rational design of kinase inhibitor selectivity
著者:: Schröder, M, 等
出版事項: (2020)

Small-molecule inhibitors of the c-Fes protein-tyrosine kinase.
著者:: Hellwig, S, 等
出版事項: (2012)

Selective bisubstrate inhibitors with sub-nanomolar affinity for protein kinase Pim-1.
著者:: Ekambaram, R, 等
出版事項: (2013)

Polynucleotide kinase as a potential target for enhancing cytotoxicity by ionizing radiation and topoisomerase I inhibitors.
著者:: Bernstein, N, 等
出版事項: (2008)

Thiazolidine derivatives as potent and selective inhibitors of the PIM kinase family.
著者:: Bataille, C, 等
出版事項: (2017)

High-throughput kinase profiling: a more efficient approach toward the discovery of new kinase inhibitors.
著者:: Miduturu, C, 等
出版事項: (2011)

Corrigendum: Dual kinase-bromodomain inhibitors for rationally designed polypharmacology.
著者:: Ciceri, P, 等
出版事項: (2014)

Identification and characterization of a small-molecule inhibitor of death-associated protein kinase 1.
著者:: Wilbek, T, 等
出版事項: (2015)

Chaperones as thermodynamic sensors of drug-target interactions reveal kinase inhibitor specificities in living cells
著者:: Taipale, Mikko, 等
出版事項: (2014)

Adaptive therapy to circumvent drug resistance to tyrosine kinase inhibitors in cancer: is it clinically relevant?
著者:: Hamdi, Amir Imran Faisal, 等
出版事項: (2022)

Inflammatory signaling by NOD-RIPK2 is inhibited by clinically relevant type II kinase inhibitors
著者:: Canning, P, 等
出版事項: (2015)

KOPI: kinase inhibitor proteome impact analysis
著者:: Li, Ginny Xiaohe, 等
出版事項: (2023)

Multiplex imaging and cellular target identification of kinase inhibitors via an affinity-based proteome profiling approach
著者:: Su, Ying, 等
出版事項: (2015)

Activation loop targeting strategy for design of receptor-interacting protein kinase 2 (RIPK2) inhibitors
著者:: Suebsuwong, C, 等
出版事項: (2018)

Cinnamomum iners as Mitogen-Activated Protein Kinase Kinase (MKK1) inhibitor
著者:: Pang, Kam Lee, 等
出版事項: (2009)

Molecular structures of cdc2-like kinases in complex with a new inhibitor chemotype
著者:: Walter, A, 等
出版事項: (2018)

Targeting tyrosine-kinases in ovarian cancer.
著者:: Morotti, M, 等
出版事項: (2013)

Structurally sophisticated octahedral metal complexes as highly selective protein kinase inhibitors.
著者:: Feng, L, 等
出版事項: (2011)

Recent progress in histone demethylase inhibitors
著者:: McAllister, T, 等
出版事項: (2016)

A comparison of protein kinases inhibitor screening methods using both enzymatic activity and binding affinity determination
著者:: Rudolf, A, 等
出版事項: (2014)

Targeting the water network in cyclin G-associated kinase (GAK) with 4-anilino-quin(az)oline inhibitors
著者:: Asquith, CRM, 等
出版事項: (2020)